SYNOPSIS: Nectar Lifescience approved an Rs. 81 crore share buyback at Rs. 27 per share, amounting to 3 crore shares via the tender route, excluding promoters, with 24th December 2025 set as the record date.

During Wednesday’s trading session, shares of a company engaged in the manufacturing of APIs and Formulations surged nearly 18 percent on BSE, after the Board of the company approved a share buyback worth Rs. 81 crores with a record date fixed on 24th December 2025.

At 10:51 a.m., the shares of Nectar Lifescience Limited were trading in the green at Rs. 20.58 on BSE, up by around 15 percent, as against its previous closing price of Rs. 17.92, with a market cap of Rs. 461.5 crores. The stock has delivered negative returns of over 40 percent in one year, and has gained by around 46

See Full Page